Disc Medicine

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Disc spins past FDA setback with ‘overwhelmingly positive’ data

The phase 3 trial met both co-primary and all secondary endpoints, positioning Disc to refile for FDA approval of its once-rejected rare disease drug.
Nick Paul Taylor Oct 19, 2026 8:00am
big wave over ship in storm

Disc lays off 20% of workforce in wake of FDA rejection

Mar 3, 2026 10:45am
Soccer goal ball score

PitchBook expects disciplined biopharma VC recovery in 2026

Feb 16, 2026 12:01am
shards of a disc in the air

Disc's rare disease drug hit by FDA rejection

Feb 13, 2026 5:00pm
accelerated

Regeneron, Sanofi receive 1- to 2-month priority review vouchers

Oct 17, 2025 8:30am
spinning plates spin balance

Disc to spin up confirmatory trial after FDA agrees to design

Jan 21, 2025 9:45am